Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. (ADVM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
advm · stock forecast · 16 analysts (3M) · FMP · updated Feb 12, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$28.00
Consensus
$8.90
+104.1% upside
Low
$2.00
Median: $5 · Last Close: $4.36
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$8.90
104.1% upside
High Target
$28
542.2%
Low Target
$2
-54.1%
Current Price
$4.36
as of today
Based on analyst price targets, the ADVM stock price prediction for the next 12 months ranges from $2 to $28. The consensus ADVM price forecast of $8.90 implies 104.1% upside from the current price of $4.36.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.39 | ↑ 0.58% |
1-day model range: $4.38–$4.39. Peak: $4.39 (+0.58%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -32.8% |
| 2028 | $2 | -43.8% |
| 2029 | $2 | -48.4% |
| 2030 | $2 | -50.5% |
| 2031 | — | -51.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADVM · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-17 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-10-28 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-09-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-26 | Mizuho | Maintains | Outperform→Outperform |
| 2025-05-15 | Chardan Capital | Maintains | Buy→Buy |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-15 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-04-17 | Chardan Capital | Maintains | Buy→Buy |
| 2025-04-16 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Adverum Biotechnologies, Inc. (ADVM) stock. Of the recent 70 rating actions, 7 were upgrades and 13 were downgrades. 16 analysts currently cover ADVM.
Analyst Recommendation Trends
ADVM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 99.6% YoY
Revenue Next Year
$15M
↑ 7500.0% YoY
EPS This Year
$-8.04
EPS Next Year
$-4.83
↓ 40.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADVM EPS of $-8.04 for the current fiscal year, based on estimates from 2 analysts. The ADVM revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ADVM stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ADVM price target is $8.90 (+104.1% upside), with an analyst consensus of Buy.
The ADVM short-term stock prediction for tomorrow is $4.39 (+0.58%). The ADVM stock price prediction for 2027 estimates an average of $3. The ADVM stock prediction for 2030 projects a range of $2–$2.
Adverum Biotechnologies, Inc. trades on NASDAQ under the ticker ADVM. The ADVM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 63% of covering analysts.
Frequently asked questions
ADVM forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month ADVM price target is $8.90, with a high forecast of $28.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies +104.1% potential upside from the current price of $4.36.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.